The COVID-19 outbreak, no less severe than the SARS outbreak in 2003 and the H1N1 outbreak in 2009, is also a new test of the international community’s ability to respond to major outbreaks of infectious diseases. The WHO, in response to the outbreak, activated the R&D Blueprint, which accelerated diagnostics, vaccines, and therapeutics for this novel coronavirus9 . Scientists and medical researchers in the US have been instructed to investigate the scientific origins of the novel coronavirus, as misinformation about the outbreak spread online10 . As a global alliance financing and coordinating the development of vaccines against emerging infectious diseases, the Coalition for Epidemic Preparedness Innovations (CEPI) launched a new call for proposals to develop vaccines against coronavirus11 . To assist in ending this epidemic, The Lancet has created a Coronavirus Resource Centre. The Journal of the American Medical Association is providing updates on diagnosis and treatment of coronavirus.